ReviewKidney diseases (Basel, Switzerland)

Lysine Methyltransferases SMYD2 and SMYD3: Emerging Targets in Kidney Diseases.

Xinyu Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.